These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2106400)

  • 1. Adverse hemodynamic effects of antiarrhythmic drugs in congestive heart failure.
    Hammermeister KE
    Circulation; 1990 Mar; 81(3):1151-3. PubMed ID: 2106400
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
    Gottlieb SS; Kukin ML; Medina N; Yushak M; Packer M
    Circulation; 1990 Mar; 81(3):860-4. PubMed ID: 2106401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congestive heart failure induced by six of the newer antiarrhythmic drugs.
    Ravid S; Podrid PJ; Lampert S; Lown B
    J Am Coll Cardiol; 1989 Nov; 14(5):1326-30. PubMed ID: 2509529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New anti-arrhythmia drugs].
    Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
    Woosley RL; Echt DS; Roden DM
    Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic effects of antiarrhythmic drugs.
    Block PJ; Winkle RA
    Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.
    Gottlieb SS; Kukin ML; Yushak M; Medina N; Packer M
    Ann Intern Med; 1989 Apr; 110(7):505-9. PubMed ID: 2493762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of antiarrhythmic agents in heart failure: implications of CAST.
    Gottlieb SS
    Am Heart J; 1989 Nov; 118(5 Pt 1):1074-7. PubMed ID: 2510486
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
    Horowitz LN; Morganroth J
    J Am Coll Cardiol; 1987 Feb; 9(2):459-63. PubMed ID: 3100601
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
    Vanhaleweyk G; Serruys PW; Hugenholtz PG
    Eur Heart J; 1984 Sep; 5 Suppl B():67-74. PubMed ID: 6437819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine.
    Alpert JS; Haffajee CI; Young MD
    Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic and hemodynamic effects of tocainide (W-36095) in man.
    Swedberg K; Pehrson J; Rydén L
    Eur J Clin Pharmacol; 1978 Nov; 14(1):15-9. PubMed ID: 729602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.